
Dictate anywhere on your screen, capture telehealth audio straight from the call,
and skip the second login.
Lorraine Quintana
Fact checked by Shine Colcol
MIMS Australia is a leading provider of medicines information for healthcare professionals nationwide. Established from the Monthly Index of Medical Specialties, first published in the early 1960s, MIMS has developed a decades-long legacy of delivering independent, evidence-based drug information that clinicians rely on in everyday practice.
Today, through its global network, MIMS supports more than two million healthcare professionals across 17 countries, reflecting both its international reach and enduring relevance at the point of care.
As a partner for Heidi’s new Evidence feature, MIMS brings its authoritative medicines into Heidi’s AI-powered workflow.
It aims to strengthen prescribing confidence, enhance medication safety, and ground clinical outputs in trusted pharmacological guidance.
Heidi surfaces authoritative MIMS drug information directly within your workflow, so you can make prescribing decisions with confidence without switching tabs or leaving the patient.
Seamless access to PBS restrictions and dosing guidance supports regulatory alignment, thereby lowering compliance risk and reducing the time spent navigating administrative requirements.
When Heidi generates medication-related outputs, they're grounded in MIMS content, so your clinical notes reflect the same trusted, TGA-aligned information that Australian clinicians have relied on for over 60 years.
"MIMS has been the cornerstone of medicines information across Australia and New Zealand (ANZ) for over 60 years. Widely used across the Healthcare ecosystem, MIMS is one of the most trusted sources of drug, medicines, and clinical decision support information across ANZ. Our partnership with Heidi Evidence ensures that ANZ clinicians can access locally relevant drug information directly within their natural documentation workflow." - Robert Best, CEO, MIMS Australia and New Zealand

The Heidi Evidence feature brings unlimited, authoritative MIMS medicine information directly into the consultation. Let’s examine how this partnership supports prescribing decisions and verification all within a single platform.
Medication safety intelligence is embedded directly within the consultation, so your prescribing decisions are supported by trusted pharmacological data in real time.
Patient communication is strengthened by translating detailed medical data into clear, practical resources aligned to any clinical context.
Your clinical judgement remains central, with AI-generated outputs aligned to authoritative source material for review and validation.
Heidi’s Evidence feature is built to support clinicians by delivering answers grounded in trusted sources. It strengthens clinical practice by surfacing answers from trusted, authoritative sources. Every response is anchored in established reference material, giving clinicians reliable guidance at the point of care without leaving the session.
“My go-to for solid clinical data in complex cases. It helps connect labs, medications, symptoms, and comorbidities into clear, logical pathways I can use in practice.” - Meg Ramstad Wallin, Holistic Nurse Practitioner
The partnership between Heidi Evidence and MIMS Australia speeds up manual drug searches with context-aware safety, ensuring every script is backed by the most trusted pharmacological database in the country.
Heidi Evidence draws from MIMS’ regularly maintained medicine database, ensuring updated product information, interaction data, and regulatory details aligned with current Australian standards.